Clinicopathological significances of PLOD2 epithelial-mesenchymal transition markers and cancer stem cells in patients with esophageal squamous cell carcinoma.
We found that PLOD2 could serve as a prognostic marker in patients with LSCC and confer drug resistance in LSCC by increasing CSC-like traits; in addition a Wnt-responsive CSC pathway was identified.
We'd like to inform you that we have updated our Privacy Notice to comply with Europe’s new General Data Protection Regulation (GDPR) that applies since 25 May 2018.